RUSSO, FRANCESCO PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.999
AS - Asia 2.197
EU - Europa 2.115
SA - Sud America 19
AF - Africa 16
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.977
CN - Cina 999
SG - Singapore 859
IT - Italia 744
FI - Finlandia 302
SE - Svezia 245
DE - Germania 226
VN - Vietnam 190
GB - Regno Unito 170
FR - Francia 154
UA - Ucraina 91
IN - India 64
RU - Federazione Russa 45
NL - Olanda 34
IE - Irlanda 28
ES - Italia 21
HK - Hong Kong 19
PK - Pakistan 16
CA - Canada 15
BR - Brasile 14
JP - Giappone 14
TW - Taiwan 14
RO - Romania 11
PL - Polonia 10
EG - Egitto 8
BE - Belgio 7
MX - Messico 7
CH - Svizzera 5
IR - Iran 5
AR - Argentina 4
CZ - Repubblica Ceca 4
AT - Austria 3
AU - Australia 3
EU - Europa 3
KR - Corea 3
PH - Filippine 3
SI - Slovenia 3
TR - Turchia 3
DK - Danimarca 2
ET - Etiopia 2
GH - Ghana 2
GR - Grecia 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SL - Sierra Leone 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BG - Bulgaria 1
EC - Ecuador 1
HU - Ungheria 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
LY - Libia 1
MA - Marocco 1
PT - Portogallo 1
RS - Serbia 1
Totale 19.355
Salva come PNG Salva come JPEG
Città #
Fairfield 2.523
Woodbridge 1.517
Houston 1.157
Chandler 1.083
Ashburn 1.073
Ann Arbor 1.041
Seattle 867
Cambridge 858
Wilmington 764
Singapore 689
Boardman 393
Santa Clara 381
Jacksonville 364
San Diego 316
Princeton 291
Beijing 242
Padova 218
Des Moines 217
Medford 207
Dong Ket 190
Helsinki 163
Roxbury 130
Nanjing 122
Guangzhou 64
Shenyang 58
Milan 52
New York 51
London 42
Falls Church 40
Hebei 33
Jinan 32
Rome 30
Dublin 27
Redwood City 26
Nanchang 23
Ogden 22
Washington 22
Jiaxing 21
Tianjin 20
Kharkiv 19
Los Angeles 19
Pune 19
Chicago 18
Shanghai 18
Zhengzhou 18
Changsha 17
Hefei 17
Hong Kong 17
Munich 17
Phoenix 16
Saint Petersburg 16
Vicenza 16
Borås 15
Kunming 15
Kilburn 13
Lappeenranta 13
Ningbo 13
Bologna 12
Paris 12
Taipei 12
Dearborn 11
Taizhou 11
Verona 11
Dallas 10
Venice 10
Fuzhou 9
Hangzhou 9
Norwalk 9
Sahiwal 9
São Paulo 9
Trieste 9
Detroit 8
Pomezia 8
Amsterdam 7
Chiswick 7
Selvazzano Dentro 7
Arezzo 6
Dolo 6
Esslingen am Neckar 6
Haikou 6
Hounslow 6
Las Vegas 6
Palermo 6
Prescot 6
Rockville 6
Southwark 6
Teramo 6
Frankfurt am Main 5
Hirakata 5
Islington 5
Livorno 5
Mumbai 5
New Bedfont 5
Nuremberg 5
Pisa 5
Taiyuan 5
Toronto 5
Treviso 5
Buenos Aires 4
Florence 4
Totale 15.974
Salva come PNG Salva come JPEG
Nome #
Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. 159
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 148
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 147
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 143
Heparanase and macrophage interplay in the onset of liver fibrosis 142
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation. 138
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 138
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 137
Understanding of and attitudes to xenotransplantation: a survey among Italian university students 135
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 134
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 133
The survival benefit of liver transplantation in hepatocellular carcinoma patients 131
Acellular liver matrix improves the survival and functions of isolated rat hepatocytes cultured in vitro 131
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 131
New Perspectives in Liver Transplantation: From Regeneration to Bioengineering 131
Inflammatory bowel disease therapies adversely affect fertility in men- A systematic review and meta-analysis 129
Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long? 125
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis 125
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 125
Study of the microcirculation in hDAF transgenic rat livers xenoperfused with human blood. 124
Use of ustekinumab in five psoriatic patients with hepatitis B virus infection 124
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 123
Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury. 123
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 122
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 122
New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation 119
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 117
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 117
Experimental hepatology applied to stem cells 117
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats 116
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 116
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 115
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 114
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis 113
Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins 112
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 112
AISF position paper on HCV in immunocompromised patients 111
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey 110
Markers of acute rejection and graft acceptance in liver transplantation. 110
Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease 110
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 109
Non Adherence To Medical Prescriptions In Liver Transplantation: A Prospective Longitudinal Study 109
Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure ? 108
Hepatitis C virus infection in end stage renal disease and kidney transplantation 108
Erratum to "A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list" [J Hepatol 2013;60:290-297]. 108
Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors 108
Management of bacterial infection in the liver transplant candidate 107
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 106
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma 106
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort 105
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 105
The bone marrow functionally contributes to liver fibrosis 104
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients 104
Compliance to medical regimen in patients before and after liver transplantation: are there any predictive factors? 103
HepaDisk – A new quality of life questionnaire for HCV patients 103
The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver 102
ESTIMATION OF THE HARM TO THE WAITING LIST AS CRUCIAL FACTOR IN THE SELECTION OF PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATION 101
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 101
Adherence in Liver Transplant Recipients 101
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 101
Risk Factors in Liver Retransplantation: A Single-Center Experience RID D-7140-2011 100
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 100
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 99
Algorithm for prioritization of patients on the waiting list for liver transplantation. 98
Hypercoagulability In Cirrhotic Patients With Hepatocellular Carcinoma (hcc) and Portal Vein Thrombosis (pvt) 98
Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice 98
Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury. 97
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients 97
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 97
Young GI angle: A young point of view on translational medicine 97
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey 96
Recent advances in understanding and managing liver transplantation 96
Stem and progenitor cells in liver regeneration and repair 96
Histological features of donor grafts for orthotopic liver transplantation 94
PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 94
Immune response and gender disparity influence liver regeneration after acute hepatic injury 94
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 94
Hepatic stem cells: from inside and outside the liver? 93
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival 93
Galectin-3 regulates myofibroblast activation and hepatic fibrosis. 93
Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) 92
HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma. 92
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 92
Bone marrow cells in the liver: diverse cells, diverse effects 91
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 91
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 91
Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations 91
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 91
Prevalence of celiac disease in adult patients with refractory functional dyspepsia: Value of routine duodenal biopsy 90
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 90
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis 90
Is liver damage due to HCV recurrence after transplantation associated with histological features of donor graft ?. 89
Skin cancer and other cutaneous disorders in liver transplant recipients. 89
Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis 89
Umbilical cord mesenchymal stem cells modulate dextran sulphate sodium induced acute colitis in immunodeficient mice. 89
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 88
Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review 87
GH/GHBP changes in the perioperative course of liver transplantation: pathophysiologic and clinical implications 87
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 87
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 87
Totale 10.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.950
article - articoli 80.810
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 164
Totale 167.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.936 0 0 0 0 0 0 354 407 408 341 261 165
2020/20212.821 140 160 150 251 132 118 163 214 335 308 366 484
2021/20223.548 155 422 376 170 149 336 325 285 184 132 349 665
2022/20232.452 498 226 72 242 392 347 61 145 256 19 164 30
2023/20241.635 80 206 178 132 134 206 156 70 78 57 167 171
2024/20252.232 24 493 339 284 836 253 3 0 0 0 0 0
Totale 19.694